Clinical trial
A Randomized Study in Non-Hodgkin's Lymphoma Patients Carrying Hepatitis B…
NCT00201318 · National Health Research Institutes, Taiwan, Other · Completed
Key facts
| NCT number | NCT00201318 |
|---|---|
| Title | A Randomized Study in Non-Hodgkin's Lymphoma Patients Carrying Hepatitis B Surface Antigen |
| Official title | A Randomized Study of Lamivudine Prophylaxis or Treatment Against Hepatitis B Reactivation in Non-Hodgkin's Lymphoma Patients Carrying Hepatitis B Surface Antigen |
| Lead sponsor | National Health Research Institutes, Taiwan, Other |
| Collaborators | National Taiwan University Hospital Mackay Memorial Hospital National Cheng-Kung University Hospital Taipei Veterans General Hospital, Taiwan Chi Mei Medical Hospital |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-Hodgkin's Lymphoma |
| Intervention type | Drug |
| Interventions | Cyclophosphamide Doxorubicin Vincristine Lamivudine |
| Enrollment | 50 |
| Start date | Sep 1, 2001 |
| Completion | Oct 1, 2005 |
| First posted | Sep 20, 2005 |
| Last update posted | Sep 20, 2005 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: